TNM staging

You have access
Tissue Prognostic Markers for Clear Cell Renal Cell Carcinoma Tumor-stroma Interaction: Impact on TNM Staging Parameters
ANDREI ALEXANDRU COSMA, ALINA GABRIELA NEGRU, OVIDIU CATALIN FERICIAN, MIHAELA MARIA PASCA FENESAN, VLAD VORNICU, ADELA MARIA FERICIAN, EUGEN MELNIC and ANCA MARIA CIMPEAN

Anticancer Research June 2025, 45 (6) 2401-2416; DOI: https://doi.org/10.21873/anticanres.17612
You have access
Chemerin and Chemokine-like Receptor 1 Are Not Prognostic in Colorectal Carcinoma
FLORIAN WEBER, RUDOLF JUNG, OLIVER TREECK and CHRISTA BUECHLER

Anticancer Research February 2023, 43 (2) 831-839; DOI: https://doi.org/10.21873/anticanres.16225
You have access
Consideration of the Optimal Surgical Procedure Based on the Risk of Recurrence in Clinical Stage 0 or IA Lung Adenocarcinoma
TOMOYOSHI TAKENAKA, TETSUZO TAGAWA, MIKIHIRO KOHNO, NAOKI HARATAKE, FUMIHIKO KINOSHITA, YUKI ONO, SHO WAKASU, YUKA OKU and MASAKI MORI

Anticancer Research February 2022, 42 (2) 1137-1142; DOI: https://doi.org/10.21873/anticanres.15577
You have access
Sentinel Lymph Node Detection by Blue Dye Versus Indocyanine Green Fluorescence Imaging in Colon Cancer
GABRIEL LIBERALE, SOPHIE VANKERCKHOVE, MARIA GOMEZ GALDON, DENIS LARSIMONT, BISSAN AHMED, FIKRI BOUAZZA, MICHEL MOREAU, ISSAM EL NAKADI, VINCENT DONCKIER, PIERRE BOURGEOIS and R&D Group for the Clinical Application of Fluorescence Imaging at the Jules Bordet Institute

Anticancer Research September 2016, 36 (9) 4853-4858;

Main menu